/Investor DB

Bios Partners — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Trefoil Therapeuticstrefoiltherapeutics.cominApr 2025✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in

BoardChristy Shaffer(Director)inRalph Bradshaw(Director)

Board seatStella Robertson· per SEC Form D

Co-investorsExSight VenturesHatteras Venture PartnersSolasta VenturesAccess BiotechnologyCorrelation VenturesFemHealth Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.